Physician profile
Hari Prabhakar
NPI 1669887311
$11,243.48
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,652 · 2020: $466 · 2021: $3,065 · 2022: $3,046 · 2023: $1,927 · 2024: $1,088.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,682 · Travel and Lodging: $1,334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.64 |
| Travel and Lodging | $1,334.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $3,121.59 | 2021-2022 | |
| Medtronic, INC. | $2,025.65 | 2021-2024 | Intellis Adaptivestim, Accurian |
| Boston Scientific Corporation | $1,247.44 | 2019-2024 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Medtronic USA, INC. | $1,107.73 | 2019 | |
| Relievant Medsystems, INC. | $1,048.77 | 2022-2023 | Intracept |
| Abbott Laboratories | $1,040.39 | 2019-2024 | Eterna |
| Curonix LLC | $506.60 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $345.94 | 2020-2024 | Sprint Pns System |
| Centinel Spine, LLC | $188.30 | 2019 | |
| Nevro Corp. | $181.58 | 2020-2021 | |
| Amgen INC. | $83.11 | 2020 | |
| Forte Bio-Pharma LLC | $74.47 | 2019-2021 | |
| Painteq LLC | $52.68 | 2023 | Painteq |
| Biodelivery Sciences International, INC. | $34.31 | 2020-2021 | |
| Pfizer INC. | $29.55 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $26.82 | 2021 | |
| Mml US, INC. | $25.96 | 2023 | Reactiv8 |
| Allergan, INC. | $22.28 | 2020 | |
| Collegium Pharmaceutical, INC. | $20.00 | 2023 | Belbuca |
| Nalu Medical, INC. | $19.06 | 2022 | |
| Horizon Therapeutics Plc | $15.34 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.47 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hari Prabhakar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.